US18507C1036
US18507C1036
ClearPoint Neuro Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 319.68M EUR | 544.18M EUR | 272.88M EUR | 401.76M EUR |
Enterprise Value | 354.27M EUR | 578.76M EUR | 300.87M EUR | 414.07M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -8.77x | -- | -- | -- |
Price to Sales | 7.56x | 12.87x | 6.72x | 14.1x |
Price to Book | 29.69x | 50.5x | 14.48x | 14.34x |
EV/Revenue | 8.38x | 13.69x | 7.41x | 14.54x |
EV/EBITDA | -12.56x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.4% | -5.75% | -9.79% | -4.5% |